Concise Communication

Validation of Surveillance in the Intensive Care Unit Component of the German Nosocomial Infections Surveillance System

I. Zuschneid, MD; C. Geffers, MD; D. Sohr, PhD; C. Kohlhase, MD; M. Schumacher, PhD; H. Rüden, MD; P. Gastmeier, MD  

From the Institute of Hygiene and Environmental Medicine, Charité‐University Medicine Berlin, Berlin (I.Z., C.G., D.S., C.K., H.R.), the Institute of Medical Biometry and Medical Informatics, Albert Ludwigs University, Freiburg (M.S.), and the Division of Hospital Epidemiology and Infection Control, Institute for Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover (P.G.), Germany. (Present affiliation: Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany [I.Z.].)

Address reprint requests to I. Zuschneid, Robert Koch Institute, Department of Infectious Disease Epidemiology, Seestrasse 10, 13353 Berlin, Germany (zuschneidi@rki.de).

A validation study was performed for the intensive care unit component of the German nosocomial infections surveillance system (Krankenhaus Infektions Surveillance System [KISS]). A total of 286 reported infections and 1,195 medical records with no reported infection from 20 randomly selected KISS intensive care units were reviewed by trained physicians. The mean sensitivity was 66% (median, 81%), and the mean specificity was 99.4% (median, 99.6%).

Received August 10, 2005; accepted January 27, 2006; electronically published March 16, 2007.

In the 1970s, the National Nosocomial Infections Surveillance (NNIS) system was established in the United States.1 Many other countries followed with similar surveillance efforts,2 and different studies showed that surveillance was associated with the reduction of nosocomial infection rates.36 The German nosocomial infection surveillance system, the Krankenhaus Infektions Surveillance System (KISS),7 began in Germany in January 1997 as a nationwide surveillance project for the voluntary reporting of nosocomial infections. KISS uses Centers for Disease Control and Prevention definitions of nosocomial infections8 and NNIS surveillance methods.1 In the intensive care unit (ICU) component, cumulative data from 323 ICUs were available in the KISS database in December 2004; most of the ICUs have participated in KISS continuously since they first joined the program. Reporting in ICUs focuses on primary bloodstream infections, urinary tract infections, and lower respiratory tract infections (LRTIs) (pneumonia and bronchitis). An investigation was performed 3 years after the implementation of the ICU component to assess the accuracy of the data on primary bloodstream infections and LRTIs reported to KISS.

Methods

 

Two physicians (I.Z. and C.K.) were trained in diagnosing nosocomial infections according to the Centers for Disease Control and Prevention definitions by means of case examples and by reviewing selected patient medical records, as described elsewhere.9 Sample size calculations showed that approximately 300 cases of LRTIs or bloodstream infections and 1,200 medical records of patients without nosocomial infections were needed for the study to achieve the desired precision (defined as half the width of the 95% confidence interval [CI]). These requirements were met by reviewing 15 medical records of patients with reported LRTIs or bloodstream infections and 60 medical records of patients without reports of these infections in 20 KISS ICUs.

The inclusion criterion for the ICUs was participation in KISS for at least half a year before the beginning of the study period in August 2000. All ICUs with a shorter duration of participation were excluded. Therefore, 20 ICUs participating in KISS were randomly chosen from a list of all 77 KISS ICUs that started KISS surveillance in February 1999 or earlier. This list was sorted by patient‐days per year to represent the size and workload of the ICU. For each ICU selected, a sample of medical records was reviewed by the trained physicians; the sample included 15 medical records from patients with bloodstream infections or LRTIs reported successively to KISS and 60 medical records from consecutively admitted patients without reports of these infections.

Diagnoses were made by the trained physicians. In cases of discrepancy with the diagnosis of the surveillance personnel, a supervising epidemiologist from the National Center of Surveillance of Nosocomial Infections was consulted.

After determining the positive predictive value (ie, the number of confirmed nosocomial infections/number of reported nosocomial infections) and the negative predictive value (number of confirmed patients without nosocomial infection reported/number of patients without reported nosocomial infection) of the diagnoses made by surveillance personnel, sensitivity and specificity were calculated according to the following Bayes formulas: sensitivity = (the positive predictive value × the reported incidence) / {(the positive predictive value × the reported incidence) + [(1 − the negative predictive value) × (1 − the reported incidence)]}; specificity = [the negative predictive value × (1 − the reported incidence)] / {[the negative predictive value × (1 − the reported incidence)] + [(1 − the positive predictive value) × the reported incidence)]}. Statistical analyses were performed with SAS statistical software, version 6.12 (SAS Institute). After validation for each ICU, the medical records were discussed between the study physicians and the surveillance personnel, and possible reasons for misdiagnoses were recorded.

Results

 

Nine surgical ICUs, 8 medical‐surgical ICUs, 2 neurosurgical ICUs, and 1 medical ICU were randomly selected for analysis. The median number of ICU beds was 12, the median number of patients admitted per year was 678, and the median number of patient‐days per year was 3,509. The number of patient‐days did not differ significantly from the median for all KISS ICUs during the same period (ie, through June 2000), which was 3,040 patient‐days. In the retrospective medical record review, a total of 1,481 cases were analyzed, including 286 reported nosocomial infections (51 bloodstream infections and 235 LRTIs) and 1,195 medical records with no reported bloodstream infections or LRTIs. A total of 242 of the reported nosocomial infections were confirmed, and 19 previously undiagnosed nosocomial infections were identified by the trained physicians (Table 1). The pooled mean of the positive predictive value of the surveillance personnel in KISS was 85% (95% CI, 79%‐89%; median, 90%), and the negative predictive value was 98.4% (95% CI, 97.5%‐99.0%; median, 98%). The overall sensitivity for the surveillance personnel of the 20 ICUs was 66% (95% CI, 54%‐77%; median, 81%), and the overall specificity was 99.4% (95% CI, 99.2%‐99.6%; median, 99.6%).

Table 1. 
Table 1.  Data on Nosocomial Infections (NIs) From the Validation Study Data and Device‐Associated Infection Rates from the Krankenhaus Infektions Surveillance System (KISS) in German Intensive Care Units

Open New Window

Discussion

 

Surveillance systems that provide reference data depend on the quality of the data reported by the single contributor. An important reason for reporting incomplete data is that participants may fear the consequences of detecting high infection rates. Thus, voluntary and anonymous participation is an essential factor for achieving valid information. However, the accuracy of reporting should be assessed periodically to promote data reliability and to find out whether there are systematic problems concerning the application of the surveillance method. Hence, 3 years after the implementation of KISS, the validity of the ICU component’s data was evaluated.

Prospective evaluation was conducted in several studies,1012 but this approach, as well as the prevalence survey evaluation,13,14 only allows assessment of a relatively small amount of data. Furthermore, in the prospective evaluation, ongoing surveillance might be influenced by the known presence of an observer. As done by several other investigators,15,16 we chose a method of retrospective medical record review to assess the accuracy of nosocomial infections surveillance data. Although the retrospective approach has certain limitations, such as loss of undocumented information, this method seems to be appropriate for the evaluation of the identification of nosocomial infections17,18; in one investigation, retrospective medical record review was found to be even more sensitive than the prospective approach.19 In our investigation, we found that discrepancies in diagnosing usually appeared because of uncertainty of the surveillance personnel in diagnosing nosocomial infections (eg, reporting of 2 cases of pneumonia in the same patient because of changes of the microorganism found) or because of surveillance gaps (eg, during personnel vacation) and not because of different approaches regarding the interpretation of the patient medical records because of missing information.

The results for the particular types of nosocomial infection found in our study are similar to those of the NNIS evaluation study15 (Table 2). However, in the NNIS study, sensitivity and specificity were calculated for the medical record sample selected for the study, whereas in our investigation we estimated sensitivity and specificity for the whole system, taking into account the incidence of nosocomial infections by applying the Bayes formulas; therefore, the comparability of the 2 investigations is limited. Furthermore, validation studies for surveillance of nosocomial infections in ICUs were performed in Belgium and France, with results comparable to our findings.20 The ratio of the true incidence to the reported incidence of the different infection types can be regarded as a corrective factor for estimating the true infection rates for pneumonia, bronchitis, and bloodstream infections in German intensive care units (Table 1).

Table 2. 
Table 2.  Comparison of the Results of the National Nosocomial Infections Surveillance Systems (NNIS) Validation Study With Results of an Evaluation of the Krankenhaus Infektions Surveillance System (KISS)

Open New Window

KISS started in 1997 with 25 ICUs participating in the ICU component. In December 2004, a total of 323 ICUs were registered. Ongoing validation is important for the credibility and acceptance of the surveillance system, and the KISS participants are clearly aware of this fact. The observers were well received and supported by the surveillance personnel in all selected units. Finding the “bad apples” that do not provide correct surveillance data is crucial. However, validation studies are time‐consuming and costly. Therefore, for continuous validation other methods have to be found to ensure data quality. In KISS, plausibility checks are implemented at the data entry level. Additionally, surveillance personnel in units with low infection or device utilization rates or other conspicuous data are contacted periodically and asked to explain their rates. If they fail to give a plausible explanation, the data of the respective unit are eliminated from the reference database. Nevertheless, validation by visiting the participating units is indispensable for detecting systematic problems with regard to surveillance and for drawing conclusions for improving the training for participants.

Conclusion

 

One of the most important aspects of surveillance systems is to provide quality management data for its participants. KISS data are appropriate for the internal quality management of the participating ICUs. However, if the data are used for assessing the situation in ICUs in Germany (eg, for cost analyses), a corrective factor is needed. This study reveals the importance of identifying invalid data from the reference database (eg, by regular validation queries searching the electronic database), and it shows the necessity of continuous training and maintaining contact with surveillance personnel.

Acknowledgments

 

We thank all KISS participants who collaborated in this study.

The study was supported by the German Ministry of Education and Research.

References

 
  • 1. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19:19‐35.
  • 2. Widmer AF, Sax H, Pittet D. Infection control and hospital epidemiology outside the United States. Infect Control Hosp Epidemiol 1999; 20:17‐21.
  • 3. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182‐205.
  • 4. Dumigan DG, Kohan CA, Reed CR, Jekel JF, Fikrig MK. Utilizing national nosocomial infection surveillance system data to improve urinary tract infection rates in three intensive‐care units. Clin Perform Qual Health Care 1998; 6:172‐178.
  • 5. Monitoring hospital‐acquired infections to promote patient safety—United States, 1990‐1999. MMWR Morb Mortal Wkly Rep 2000; 49:149‐153.
  • 6. Zuschneid I, Schwab F, Geffers C, Ruden H, Gastmeier P. Reducing central venous catheter‐associated primary bloodstream infections in intensive care units is possible: data from the German nosocomial infection surveillance system. Infect Control Hosp Epidemiol 2003; 24:501‐505.
  • 7. Gastmeier P, Geffers C, Sohr D, Dettenkofer M, Daschner F, Ruden H. Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). Am J Infect Control 2003; 31:316‐321.
  • 8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128‐140.
  • 9. Gastmeier P, Geffers C, Daschner F, Rüden H. Diagnostisches Training für die Surveillance nosokomialer Infektionen: was ist möglich und sinnvoll? Zentralbl Hyg Umweltmed 1998; 201:153‐166.
  • 10. Wenzel RP, Osterman CA, Townsend TR, et al. Development of a statewide program for surveillance and reporting of hospital‐acquired infections. J Infect Dis 1979; 140:741‐746.
  • 11. Broderick A, Mori M, Nettleman MD, Streed SA, Wenzel RP. Nosocomial infections: validation of surveillance and computer modeling to identify patients at risk. Am J Epidemiol 1990; 131:734‐742.
  • 12. Cardo DM, Falk PS, Mayhall CG. Validation of surgical wound surveillance. Infect Control Hosp Epidemiol 1993; 14:211‐215.
  • 13. Eickhoff TC, Brachman PW, Bennett JV, Brown JF. Surveillance of nosocomial infections in community hospitals. I: Surveillance methods, effectiveness, and initial results. J Infect Dis 1969; 120:305‐317.
  • 14. Poulsen KB, Meyer M. Infection registration underestimates the risk of surgical wound infections. J Hosp Infect 1996; 33:207‐215.
  • 15. Emori TG, Edwards JR, Culver DH, et al. Accuracy of reporting nosocomial infections in intensive‐care‐unit patients to the National Nosocomial Infections Surveillance System: a pilot study. Infect Control Hosp Epidemiol 1998; 19:308‐316.
  • 16. Ehrenkranz NJ, Shultz JM, Richter EL. Recorded criteria as a “gold standard” for sensitivity and specificity estimates of surveillance of nosocomial infection: a novel method to measure job performance. Infect Control Hosp Epidemiol 1995; 16:697‐702.
  • 17. Haley RW, Schaberg DR, McClish DK, et al. The accuracy of retrospective chart review in measuring nosocomial infection rates: results of validation studies in pilot hospitals. Am J Epidemiol 1980; 111:516‐533.
  • 18. Belio‐Blasco C, Torres‐Fernandez‐Gil MA, Echeverria‐Echarri JL, Gomez‐Lopez LI. Evaluation of two retrospective active surveillance methods for the detection of nosocomial infection in surgical patients. Infect Control Hosp Epidemiol 2000; 21:24‐27.
  • 19. Blake S, Cheatle E, Mack B. Surveillance: retrospective versus prospective. Am J Infect Control 1980; 8:75‐78.
  • 20. Morales I. Overview about results of ICU validation studies. In: Program and abstracts of the HELICS Symposium. 2004. Available at: http://helics.univ‐lyon1.fr/conference/7b.pdf. Accessed January 11, 2006.
© 2007 by The Society for Healthcare Epidemiology of America. All rights reserved.